QT
ALDR

Quantamental Technologies’s Alder Biopharmaceuticals ALDR Stock Holding History

Quantamental Technologies’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,244
Closed -$156K – 1980
2019
Q2 		$156K Buy
+13,244
New +$160K 0.06% 525

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantamental Technologies's ALDR Position: Q3 2019 in Review

Quantamental Technologies sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 13,244 shares — an estimated $156K sold.

Quantamental Technologies first reported a position in ALDR in Q2 2019 and held it in 1 quarter. The position peaked at $156K in Q2 2019. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Quantamental Technologies reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 13,244 Alder Biopharmaceuticals shares in Q3 2019, an estimated $156K.
  • Quantamental Technologies first reported a position in Alder Biopharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Quantamental Technologies's Alder Biopharmaceuticals position peaked at $156K in Q2 2019.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.